AcornMed Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $29.8M

  • Investors
  • 7

AcornMed General Information

Description

Provider of tumor genetic testing and detection services intended for precision oncology and recurrence monitoring. The company offers solid tumor profiling, hematologic malignancy diagnostics, and minimal residual disease monitoring, enabling hospitals and pharmaceutical partners to access genomic data and biomarker analysis for personalized patient care and companion diagnostic development.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 601, 5th Floor, Building 3, Zone 4
  • Number 22, Jinghai Fourth Road, Beijing Economic-Technological Development Area
  • Beijing, 100176
  • China
+86 010
Primary Industry
Laboratory Services (Healthcare)
Corporate Office
  • Room 601, 5th Floor, Building 3, Zone 4
  • Number 22, Jinghai Fourth Road, Beijing Economic-Technological Development Area
  • Beijing, 100176
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AcornMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series B) 13-Jul-2022 $29.8M Completed Generating Revenue
4. Early Stage VC 13-Apr-2021 Completed Generating Revenue
3. Early Stage VC (Series A) 09-Apr-2020 Completed Generating Revenue
2. Early Stage VC 12-Nov-2019 Completed Generating Revenue
1. Seed Round 25-Apr-2018 Completed Startup
To view AcornMed’s complete valuation and funding history, request access »

AcornMed Patents

AcornMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025055298-A1 Gene marker combination, kit, and detection method Inactive 11-Sep-2023

AcornMed Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Elikon Venture Growth/Expansion Minority
Yikai Venture Capital Growth/Expansion Minority
Sino Ocean Investment Corporation Minority
Sino-Ocean Capital Asset Manager Minority
Indaco Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

AcornMed FAQs

  • When was AcornMed founded?

    AcornMed was founded in 2018.

  • Where is AcornMed headquartered?

    AcornMed is headquartered in Beijing, China.

  • What industry is AcornMed in?

    AcornMed’s primary industry is Laboratory Services (Healthcare).

  • Is AcornMed a private or public company?

    AcornMed is a Private company.

  • What is the current valuation of AcornMed?

    The current valuation of AcornMed is .

  • What is AcornMed’s current revenue?

    The current revenue for AcornMed is .

  • How much funding has AcornMed raised over time?

    AcornMed has raised $44M.

  • Who are AcornMed’s investors?

    Elikon Venture, Yikai Venture Capital, Sino Ocean Investment, Sino-Ocean Capital, and Indaco Capital are 5 of 7 investors who have invested in AcornMed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process